Cognitive Behavioral Therapy for Insomnia

US Psychiatry, 2009;2(1):61-64

Abstract

Complaints of insomnia are very common in the general population and the condition is associated with a range of adverse consequences. While pharmacotherapy is the most common form of treatment, recent evidence shows that cognitive behavioral therapy (CBT) is superior in both the short- and long-term management of insomnia. In this article, the treatment rationale of CBT for insomnia is presented and the evidence for its effects and benefits are discussed. Future directions in terms of treatment efficacy and effectiveness are also presented.
Keywords
Insomnia, treatment, cognitive behavioral therapy (CBT), sleep problems
Disclosure The author has no conflicts of interest to declare.
Received: March 28, 2008 Accepted December 19, 2008
Correspondence: Børge Sivertsen, PhD, Department of Clinical Psychology, University of Bergen, Christiesgt. 12, 5015 Bergen, Norway. E: borge.sivertsen@psykp.uib.no

Sleep problems are becoming increasingly common in the general population. Studies from a range of western countries show that nearly one-third of people report insomnia symptoms, 10% experience additional daytime consequences, and 6% fulfill the diagnostic criteria for insomnia. Insomnia is more frequent in women, older adults, and patients with physical or psychiatric disorders.1 The core symptoms of insomnia include difficulties initiating or maintaining sleep, or experiencing non-restorative sleep that results in clinically significant distress or an impairment in daytime functioning. People with insomnia are commonly classified as suffering from primary or secondary/ comorbid insomnia. While the diagnosis of primary insomnia is made when the sleep problems are not caused by any known physical or mental condition, secondary insomnia refers to poor sleep that is either caused or worsened by another disorder. Approximately 25% of chronic insomniacs are thought to suffer from primary insomnia with no known secondary etiology.

The adverse consequences of insomnia are well documented. Insomnia is associated with both cognitive and intellectual impairment,2,3 as well as current and subsequent affective disorders.4–6 Patients suffering from insomnia commonly report a significant reduction in quality of life7 and impaired coping abilities,8 and insomnia has also been linked to reduced immune function and mortality.9,10 Insomniacs also typically report a lower working capacity, and insomnia has been shown to predict both long-term sick-leave and permanent work disability.11,12 In terms of economic costs, the most recent analysis of the economic burden of insomnia in the US estimated the direct medical costs of insomnia to be $13.9 billion annually,13 which increases to $92–107 billion if including indirect costs from sleep-related accidents and lost productivity.14

The mechanisms underlying the pathophysiology of insomnia are still poorly understood, but whether a person develops chronic insomnia seems to depend on predisposing traits, precipitating events, and perpetuating conditions.15 For example, acute (adjustment) insomnia is typically precipitated by a physical illness, psychosocial stressor, or other life event, but is usually short-lived as the adverse event or condition alleviates with time. However, some people continue to experience sleep problems long after the evoking factors have disappeared. In chronic insomnia, there is now a general consensus that cognitive and behavioral mechanisms play important roles in maintaining and exacerbating sleep problems.

References:
  1. Ohayon MM, Sleep Med Rev, 2002;6:97–111.
  2. Pilcher JJ, Huffcutt AI, Sleep, 1996;19:318–26.
  3. Szelenberger W, Niemcewicz S, Acta Neurobiol Exp, 2000;60:373.
  4. Mellinger GD, Balter MB, Uhlenhuth EH, Arch Gen Psychiatry, 1985;42:225–32.
  5. Neckelmann D, Mykletun A, Dahl AA, Sleep, 2007;30:873–80.
  6. Vollrath M, Wicki W, Angst J, Eur Arch Psychiatry Neurol Sci, 1989;239:113–24.
  7. Zammit GK, Weiner J, Damato N, et al., Psychosomatic Med, 2003;65:259–67.
  8. Neckelmann D, Bjerkeset O, Sivertsen B, et al., Eur Psychiat, 2006;21:S178.
  9. Savard J, Laroche L, Simard S, et al., Psychosomatic Med, 2003;65:211–21.
  10. Sivertsen B, Overland S, Neckelmann D, et al., Am J Epidemiol, 2006;163:1018–24.
  11. Akerstedt T, Kecklund G, Alfredsson L, et al., J Sleep Res, 2007;16:341–5.
  12. Walsh J, Engelhardt C, Sleep, 1999;22:S379–93.
  13. Stoller MK, Clin Ther, 1994;16:873–97.
  14. Spielman AJ, Glovinsky P, Case studies in insomnia, New York: Plenum Press, 1991:1–15.
  15. Edinger JD, Means MK, Clin Psychol Rev, 2005;25:539–58.
  16. Riedel BW, Lichstein KL, Behav Res Ther, 2001;39:201–12.
  17. Buscemi N, Vandermeer B, Friesen C, et al., Manifestations and management of chronic insomnia in adults, Rockville, 2005.
  18. Walsh JK, Krystal AD, Amato DA, et al., Sleep, 2007;30:959–68.
  19. National Institutes of Health, NIH State-of-the-Science Conference Statement on Manifestations and Management of Chronic Insomnia in Adults Consensus Statement, 2005;8:1–22.
  20. Glass J, Lanctot KL, Herrmann N, et al., BMJ, 2005;331:1169.
  21. Morin CM, Insomnia: psychological assessment and management, New York: Guilford Press, 1993.
  22. Morgan K, Thompson J, Dixon S, et al., J Psychosom Res, 2003;54:21–9.
  23. Morin CM, Hauri PJ, Espie CA, et al., Sleep, 1999;22:1134–56.
  24. Bootzin RR, Nicassio PM, Progress of Behavior Modification, New York, NY: Academic Press, 1978:1–45.
  25. Hauri P, Case studies in insomnia, New York: Plenum Medical Book, 1991.
  26. Beck AT, Cogntive therapy and the emotional disorders, New York: International University Press, 1976.
  27. Jacobsen E, You can sleep well, New York, NY: McGraw–Hill Book Company, 1938.
  28. Irwin MR, Cole JC, Nicassio PM, Health Psychology, 2006;25:3–14.
  29. Morin CM, Culbert JP, Schwartz SM, Am J Psychiatry, 1994;151:1172–80.
  30. Murtagh DR, Greenwood KM, J Consult Clin Psychol, 1995;63:79–89.
  31. Morin CM, Bootzin RR, Buysse DJ, et al.,Sleep, 2006;29:1398–1414.
  32. Sivertsen B, Omvik S, Pallesen S, et al., JAMA, 2006;295:2851–8.
  33. Omvik S, Sivertsen B, Pallesen S, et al., Sleep Bio Rhythms, 2007;5:A157.
  34. Smith MT, Huang MI, Manber R, Clin Psychol Rev, 2005;25:559–92.
  35. Cannici J, Malcolm R, Peek LA, J Behav Ther Exp Psychiatry, 1983;14:251–6.
  36. Davidson JR, MacLean AW, Brundage MD, et al., Soc Sci Med, 2002;54:1309–21.
  37. Quesnel C, Savard J, Simard S, et al., J Consult Clin Psychol, 2003;71:189–200.
  38. Simeit R, Deck R, Conta-Marx B, Support Care Cancer, 2004;12:176–83.
  39. Morin CM, Kowatch RA,Wade JB, J Behav Ther Exp Psychiatry, 1989;20:295–302.
  40. Currie SR, Wilson KG, Pontefract AJ, et al., J Consult Clin Psychol, 2000;68:407–16.
  41. Dreher HM, J Psychosom Res, 2003;54:191–8.
  42. Kuo T, Manber R, Loewy D, Sleep, 2001;14:A62.
  43. Manber R, Loewy D, Kuo T, et al., Sleep, 2001;24:A63.
  44. Morawetz D, Aust Fam Physician, 2000;29:1016.
  45. Krakow B, Johnston L, Melendrez D, et al., Am J Psychiatry, 2001;158:2043–7.
  46. Greeff AP, Conradie WS, Psychol Rep, 1998;82:407–12.
  47. Stepanski EJ, Rybarczyk B, Sleep Med Rev, 2006;10:7–18.
  48. Espie CA, MacMahon KM, Kelly HL, et al., Sleep, 2007;30:574–84.
  49. Morgan K, Dixon S, Mathers N, et al., Brit J Gen Pract, 2003;53:923–8.
  50. Bastien CH, Morin CM, Ouellet MC, et al., J Consult Clin Psych, 2004;72:653–9.
  51. Morin C, Beaulieu-Bonneau S, LeBlanc M, et al., Sleep, 2005;28:1319–27.
  52. Strom L, Pettersson R, Andersson G,J Consult Clin Psych, 2004;72:113–20.
  53. Harvey AG, Tang NK, Sleep Med Rev, 2003;7:237–62.